Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

Therapeutic efficacy of mesenchymal stem cell expressing cytosine deaminase with prodrug 5-FC according to dihydropyrimidine dehydrogenase (DPD) expression levels in GBM

Taemoon Chung, Mi Jeong Kim, Dong Soo Lee, June-Key Chung and Hyewon Youn
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1325;
Taemoon Chung
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mi Jeong Kim
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dong Soo Lee
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
June-Key Chung
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyewon Youn
1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 1325

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Taemoon Chung1,
  2. Mi Jeong Kim1,
  3. Dong Soo Lee1,
  4. June-Key Chung1 and
  5. Hyewon Youn1
  1. 1Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: March 2015 to April 2025

AbstractFullPdf
Mar 2015300
Apr 2015200
Jun 2015300
Jul 2015100
Aug 2015200
Sep 2015400
Feb 2016300
Mar 2016400
May 2016300
Jun 2016500
Jul 20161400
Aug 2016400
Sep 2016300
Oct 2016200
Nov 2016400
Dec 2016500
Jan 2017400
Feb 20171200
Mar 2017500
Apr 2017100
May 2017200
Jun 2017300
Jul 2017700
Aug 2017200
Sep 2017200
Oct 2017600
Nov 2017100
Dec 2017100
Jan 2018200
Mar 2018100
May 2018300
Jun 2018200
Jul 2018100
Sep 2018500
Oct 2018100
Nov 2018100
Jan 2019200
Mar 2019400
Jun 2019200
Jul 2019200
Aug 2019400
Oct 2019100
Nov 2019300
Dec 2019100
Jan 2020100
Feb 2020200
Mar 2020100
Apr 2020200
May 2020200
Jun 2020100
Aug 2020100
Sep 2020200
Nov 2020100
Dec 2020200
Jan 2021400
Feb 2021600
Mar 2021400
Apr 20211100
May 2021400
Jun 20212700
Jul 20217300
Aug 20213700
Sep 2021200
Oct 2021200
Nov 2021200
Dec 2021600
Jan 2022300
Feb 2022300
Mar 2022300
Apr 2022100
May 2022300
Jun 2022300
Aug 2022600
Sep 2022100
Oct 2022200
Jan 2023100
Mar 2023200
Apr 2023200
May 2023200
Jun 2023100
Jul 2023300
Aug 2023200
Sep 2023200
Oct 2023400
Nov 2023100
Dec 2023400
Jan 2024500
Mar 2024600
Apr 2024200
May 2024400
Jun 2024100
Jul 20245000
Aug 20245400
Sep 2024900
Oct 2024200
Nov 2024400
Dec 2024600
Jan 2025100
Feb 2025400
Mar 2025300
Apr 2025500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Therapeutic efficacy of mesenchymal stem cell expressing cytosine deaminase with prodrug 5-FC according to dihydropyrimidine dehydrogenase (DPD) expression levels in GBM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Therapeutic efficacy of mesenchymal stem cell expressing cytosine deaminase with prodrug 5-FC according to dihydropyrimidine dehydrogenase (DPD) expression levels in GBM
Taemoon Chung, Mi Jeong Kim, Dong Soo Lee, June-Key Chung, Hyewon Youn
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1325;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Therapeutic efficacy of mesenchymal stem cell expressing cytosine deaminase with prodrug 5-FC according to dihydropyrimidine dehydrogenase (DPD) expression levels in GBM
Taemoon Chung, Mi Jeong Kim, Dong Soo Lee, June-Key Chung, Hyewon Youn
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1325;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Lipotecan acts synergistically in combination with 188Re-liposome in hepatocellular carcinoma xenograft mouse model
  • 177mLu impurity: Practical aspects of 177mLu hospital waste management
  • Radioimmunoimaging and Radioimmunotherapy of Prostate Cancer. Preclinical evaluation of kallikrein related peptidase 2 targeting
Show more Oncology: Basic, Translational & Therapy

MTA I: Basic Science (Oncology) Posters

  • Axl-targeted optical imaging in lung tumor xenografts
  • Effect of mAb B3 and paclitaxel doses on accumulation and penetration of B3 into tumor
Show more MTA I: Basic Science (Oncology) Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire